(Q37649465)

21 August 2017

1 reference

title

The role of testosterone in erectile dysfunction (English)

1 reference

21 August 2017

1 reference

1 reference

1

Giovanni Corona

1 reference

21 August 2017

2

Mario Maggi

1 reference

PubMed ID

19997070

21 August 2017

language of work or name

English

0 references

publication date

8 December 2009

1 reference

21 August 2017

Nature Reviews Urology

1 reference

21 August 2017

7

1 reference

21 August 2017

1

1 reference

21 August 2017

46-56

1 reference

https://scigraph.springernature.com/pub.10.1038/nrurol.2009.235

21 August 2017

0 references

cites work

Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: a potential mechanism for veno-occlusive dysfunction in androgen deficiency

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Which patients with sexual dysfunction are suitable for testosterone replacement therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Hyperprolactinemia affects spermiogenesis in adult male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Testosterone and dominance in men.

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

21 January 2018

12 December 2020

Hysterical traits are not from the uterus but from the testis: a study in men with sexual dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Structured interview on erectile dysfunction (SIEDY): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

The dark side of testosterone deficiency: III. Cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Obesity, low testosterone levels and erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Gonadotropin-releasing hormone secretion from hypothalamic neurons: stimulation by insulin and potentiation by leptin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Role of brain insulin receptor in control of body weight and reproduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Testosterone and erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Effects of androgens on the expression of nitric oxide synthase mRNAs in rat corpus cavernosum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Testosterone Regulates RhoA/Rho-Kinase Signaling in Two Distinct Animal Models of Chemical Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Effects of Castration and Androgen Replacement on Erectile Function in a Rabbit Model1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

The relationship of serum testosterone to erectile function in normal aging men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Sexual differentiation of the brain and behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

The endocrinology of sexual arousal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Psycho-biological correlates of hypoactive sexual desire in patients with erectile dysfunction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Hyperprolactinemia and sexual function in men: a short review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

The impotent couple: low desire.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Effect of hyperprolactinemia in male patients consulting for sexual dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Endocrine aspects of sexual dysfunction in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Prolactin-Secreting Tumors and Hypogonadism in 22 Men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

PRL secreting adenomas in male patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Autoeroticism, mental health, and organic disturbances in patients with erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Multiple partners are associated with higher testosterone in North American men and women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Sexual Infidelity Among Married and Cohabiting Americans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

The social endocrinology of dominance: basal testosterone predicts cortisol changes and behavior following victory and defeat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Testosterone and human aggression: an evaluation of the challenge hypothesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Effects of testosterone on mood, aggression, and sexual behavior in young men: a double-blind, placebo-controlled, cross-over study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Effects of Sexual Activity on Beard Growth in Man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Sexual inactivity results in reversible reduction of LH bioavailability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Decreased pituitary-gonadal secretion in men with obstructive sleep apnea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Validation of a screening questionnaire for androgen deficiency in aging males

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Can results of the Aging Males' Symptoms (AMS) scale predict those of screening scales for androgen deficiency?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Comparison of screening questionnaires for the diagnosis of hypogonadism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Advances in male hormone substitution therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

The latest options and future agents for treating male hypogonadism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Current and future testosterone delivery systems for treatment of the hypogonadal male

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

The relationship between hypogonadism and erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Effects of testosterone on sexual function in men: results of a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Significance of hypogonadism in erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Clinical practice. Erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Sexual dysfunction in men and women with endocrine disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Effects of androgen treatment in impotent men with normal and low levels of free testosterone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

A novel therapy with testosterone and sildenafil for erectile dysfunction in patients on renal dialysis or after renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Role of androgens in erectile function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Testosterone therapy can enhance erectile function response to sildenafil in patients with PADAM: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Efficacy of sildenafil in male dialysis patients with erectile dysfunction unresponsive to erythropoietin and/or testosterone treatments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Adjunctive use of AndroGel (testosterone gel) with sildenafil to treat erectile dysfunction in men with acquired androgen deficiency syndrome after failure using sildenafil alone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Testosterone and erectile function in hypogonadal men unresponsive to tadalafil: results from an open-label uncontrolled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Sildenafil improves sleep-related erections in hypogonadal men: evidence from a randomized, placebo-controlled, crossover study of a synergic role for both testosterone and sildenafil on penile erections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

Smooth muscle cell calcium activation mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.235

American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update.

31 March 2020

1 reference

12 December 2020

Psychobiological correlates of extramarital affairs and differences between stable and occasional infidelity among men with sexual dysfunctions.

1 reference

12 December 2020

The effects of exogenous testosterone on sexuality and mood of normal men.

1 reference

12 December 2020

NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence

1 reference

12 December 2020

Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials

1 reference

12 December 2020

A critical evaluation of simple methods for the estimation of free testosterone in serum.

1 reference

12 December 2020

Testosterone supplementation for erectile dysfunction: results of a meta-analysis

1 reference

12 December 2020

Testosterone and sexual activity.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2009.235

1 reference

release_uxjafxovv5dqhjkoukz67hicqe

21 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uxjafxovv5dqhjkoukz67hicqe

24 November 2022

mapped directly with Wikidata item

PubMed ID

19997070

1 reference

PubMed ID

19997070